Smith & Nephew: Advancing Global Health Through Innovative Medical Technology
Smith & Nephew, a 170-year-old global medical technology company, is transforming patient care worldwide through cutting-edge solutions in orthopedics, sports medicine, wound care, and ENT. Led by Deepo Nath, CEO, the company leverages a rich heritage of innovation to deliver life-changing medical devices, digital solutions, and surgical technologies that enable patients to lead lives unlimited.
“Our purpose is clear: to make patients better and help them live life without limits through innovation and excellence in medical technology.”
Leadership and Purpose-Driven Culture
Deepo Nath brings a vision for strategic transformation, operational excellence, and growth. Under his leadership, Smith & Nephew has strengthened its culture of innovation, delivering technologies that redefine standards of care. From artificial joints in orthopedics to advanced wound care therapies, the company focuses on improving patient outcomes and empowering healthcare professionals worldwide.
“Innovation is at the heart of what we do — developing solutions that truly improve patient lives and support surgeons in delivering better care.”
Global Reach and Market Impact
Headquartered in London and operating in over 70 countries, Smith & Nephew serves hospital systems, surgeons, nurses, and clinicians worldwide. With the U.S. market contributing over 50% of revenue, the company maintains a strong presence in its key growth regions while ensuring local manufacturing and supply chain excellence.
“Being a global company allows us to scale innovation and deliver high-quality care to patients everywhere.”
Breakthrough Technologies
Smith & Nephew continues to pioneer highly disruptive medical technologies. Notable innovations include:
- Tessa – A minimally invasive spatial surgery platform for tendon and ligament repair, enabling surgeons to plan and execute procedures with unprecedented precision.
- Corey – A robotic orthopedic platform that optimizes joint replacement surgeries, reducing variability and improving patient outcomes.
- Pico – A single-use negative pressure therapy for wound care that accelerates healing and reduces infection risk, now adapted for home and non-hospital settings.
“These innovations exemplify how we combine technology and care to improve patient experiences and outcomes.”
Strategic Growth and Financial Outlook
Through its RISE strategy, Smith & Nephew is accelerating growth, profitability, and shareholder value. The company targets 6–7% revenue growth, 9–10% profit growth, and aims to generate $1 billion in free cash flow by 2028, while improving return on capital from 9% to 12–13%. Strategic M&A and investments will further strengthen its leading portfolio and global presence.
“RISE is about taking the company to new heights — accelerating growth, improving margins, and expanding our impact on global healthcare.”
Looking Ahead
Smith & Nephew is focused on driving innovation, improving surgical outcomes, and expanding access to advanced care. By combining heritage, purpose, and cutting-edge technology, the company is poised to elevate global medical care and deliver sustainable growth for the next generation of patients.
“The next chapter for Smith & Nephew is about reaching new levels of impact, growth, and innovation, helping patients live better lives around the world.”
